Comparison of Four Different Aberrometers for Evaluation of Higher Order Visual Aberrations

December 19, 2011 updated by: Massachusetts Eye and Ear Infirmary

An aberrometer measures visual aberrations by mapping how light rays travel through the eye and by providing maps using colored gradients to represent the magnitude of refractive errors of the eye.

The purpose of this study is to compare 4 different aberrometers -Wavescan (Visx Technology), Zywave (Bausch & Lomb), Ladarwave aberrometer (Alcon Inc.) and Allegro Analyzer (Alcon Inc). In particular, the investigators propose to focus on the ability of these devices to display the higher order visual aberrations and to compare the quality of outputs from these 4 devices in normal healthy subjects.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

21

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02114
        • Massachusetts Eye and Ear Infirmary

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Normal subjects over the age of 18 with visual abberations.

Description

Inclusion Criteria:

  • male or female, at least 18 years of age
  • no ocular abnormality other than refractive error
  • patient in generally good & stable overall health
  • has not worn contact lenses (hard or gas permeable lenses for at least 3 weeks and soft lenses for at least 3 days) prior to the study exam
  • corneal topography must be normal, as judged by the investigator
  • topical anesthesia and mydriatics must be tolerated
  • patient must be able to fixate steadily
  • ability to understand and provide informed consent to participate in this study

Exclusion Criteria:

  • history of ocular surgery
  • history of ocular trauma, infection, disease, or abnormality other than refractive error
  • myopia or hyperopia > 7.0 D, astigmatism >3.0 D
  • uncorrectable visual acuity below 20/20
  • abnormal corneal topography pattern including, but not limited to keratoconus, forme fruste keratoconus, or corneal warpage
  • pupil sizes below 6.0 mm under mydriasis
  • iris problems including, but not limited to, coloboma and previous iris surgery
  • ocular media problems, corneal, lens and/or vitreous opacities including, but not limited to cataract
  • ocular movement abnormalities including, but not limited to, strabismus or nystagmus
  • phenol red thread test (Zone Quick-Menicon Ltd) less than 9 mm/15 seconds
  • pregnancy and lactation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Time Perspectives: Prospective

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Roberto Pineda, MD, Massachusetts Eye and Ear Infirmary

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2010

Primary Completion (Actual)

July 1, 2011

Study Completion (Actual)

July 1, 2011

Study Registration Dates

First Submitted

October 27, 2010

First Submitted That Met QC Criteria

October 27, 2010

First Posted (Estimate)

October 28, 2010

Study Record Updates

Last Update Posted (Estimate)

December 21, 2011

Last Update Submitted That Met QC Criteria

December 19, 2011

Last Verified

December 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • 09-03-016

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Normal Individuals With Visual Aberrations

Subscribe